P6_TA-PROV(2005)0045 on the European Environment and Health Action Plan 2004-2010 ( 2004/2132(INI) ), report by F. Ries A6-0008/2005 . which considers that, without prejudice to existing Community legislation and following the opinion of the Scientific Committee on Health and Environment Risks, urgent consideration is to be given to restricting the marketing and/or the use on the European market of dangerous substances, to which new-born babies, children, pregnant women, elderly persons, workers and other high-risk sections of the population are heavily exposed, as safer alternatives become available, including six products from the phthalate family (DEHP, DINP, DBP, DIDP, DNOP, BBP) in domestic products for indoor use and medical devices, except where such a restriction would have a negative impact on medical treatment.
P6_TA-PROV(2005)0045 on the European Environment and Health Action Plan 2004-2010 ( 2004/2132(INI) ), report by F. Ries A6-0008/2005 . which considers that, without prejudice to existing Community legislation and following the opinion of the Scientific Committee on Health and Environment Risks, urgent consideration is to be given to restricting the marketing and/or the use on the European market of dangerous substances, to which new-born babies, children, pregnant women, elderly persons, workers and other high-risk sections of the population are heavily exposed, as safer alternatives become available, including six products from the phthalate family (DEHP, DINP, DBP, DIDP, DNOP, BBP) in domestic products for indoor use and medical devices, except where such a restriction would have a negative impact on medical treatment.